Hypertension Drugs Market Is Growing at the CAGR of 3.1% and Expected to Reach to US $5.31 Billion by 2022
Some of the key players in this market are: Abbott (US), Johnson & Johnson Services, Inc. (US), Novartis (Switzerland), GlaxoSmithKline plc.(UK), AstraZeneca (UK), Bayer AG (Germany), Pfizer Inc.(US), Merck & Co., Inc. (US), Sanofi (France), F. Hoffmann-La Roche Ltd (Switzerland), Gilead (US)
View full press release